在孟加拉国的一项病例控制研究中,对脊柱裂风险变异进行全基因组分析
Gwen Tindula1,2, Biju Issac3, Sudipta Kumer Mukherjee4
1Department of Neurology, Boston Children's Hospital, Boston, Massachusetts, USA.
Birth defects research
|March 25, 2024
概括
这项研究在孟加拉国人口中确定了三种新的脊柱裂遗传风险因素. 这些发现扩大了我们对神经管缺陷原因的理解,超出了叶酸代谢.
科学领域:
- 遗传学 遗传学 是一个
- 出生缺陷 产生的缺陷
- 基因组研究 基因组研究
背景情况:
- 神经管缺陷 (NTDs) 是严重的出生缺陷,具有长期后果.
- 之前的遗传研究集中在有限的候选基因上,主要是在叶酸代谢中.
- 在遗传研究中代表性不足的人群限制了对NTD病因学的理解.
研究的目的:
- 调查与脊柱裂风险相关的全基因组遗传变异.
- 在孟加拉国人口中确定NTD的新型遗传风险因素.
- 扩大对涉及NTD发展的生物学途径的理解.
主要方法:
- 病例控制研究设计,包括孟加拉国112例和121例对照.
- 使用Illumina全球选阵列对唾液DNA进行全基因组基因型化.
- 传输不平衡测试 (TDT) 对128个三元组进行了分析.
主要成果:
- 确定了三个新型异常脊柱裂纹风险位点:rs140199800 (SULT1C2),rs45580033 (ASB2) 和rs75426652 (LHPP).
- 这些位点通过三组的TDT分析来确定,具有很高的统计意义 (p < 10-7).
- 在病例控制或包括母亲的分析中没有发现全基因组显著变异.
结论:
- 发现了三种与脊柱裂相关的新型单核酸多态 (SNP).
- 这些SNP涉及以前与神经管缺陷无关的生物途径.
- 建议在更大的队列中进行进一步的复制研究,以验证发现并告知预防.
更多相关视频
05:51A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia
Published on: June 15, 2011
25.8K
08:22A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations
Published on: December 1, 2017
8.6K
相关概念视频
Genome-wide Association Studies-GWAS
13.4K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
13.4K
Single Nucleotide Polymorphisms-SNPs
15.0K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
15.0K
